9 Results

People

  1. Landgren
    Landgren
  2. Hultcrantz
    Hultcrantz
  3. Korde
    Korde
  4. Mailankody
    Mailankody
  5. Hassoun
    Hassoun
  6. Lesokhin
    Lesokhin
  7. Shah
    Shah
  8. Tan
    Tan
  9. Chung
    Chung
  10. Derkach
    Derkach

Groups

  1. Center for Hematologic Malignancies (9)
  2. Hematologic Malignancies Research (9)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Myeloma (7)
  6. Sloan Kettering Institute Postdocs (5)
  7. Survivorship Research (4)
  8. CTCR Scholars (3)
  9. Epidemiology and Biostatistics (3)
  10. GSK Faculty (3)
  1. "Hematologic Malignancies Research"
  2. "John Wiley & Sons, Inc."
Formats
  1. Journal Article (5)
  2. Research Letter (2)
  3. Review (2)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Hematologic Malignancies Research (9)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Myeloma (7)
  6. Sloan Kettering Institute Postdocs (5)

More Groups

People
  1. Carl Landgren (5)
  2. Malin Hultcrantz (4)
  3. Neha Korde (4)
  4. Sham Mailankody (4)
  5. Alexander Lesokhin (3)
  6. Carlyn Rose Tan (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2019 (3)
  5. 2016 (1)
Publications
  1. American Journal of Hematology (8)
  2. Current Protocols (1)
Publishers
  1. John Wiley & Sons, Inc. (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach
    Journal Article

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Flynn, J.; Salvatore, S. P.; Jaffer-Sathick, I.; Rossi, A. C.; Lahoud, O.; Hultcrantz, M.; Shah, U. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
    Research Letter

    Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Profiling and validation of live-cell protein methylation with engineered enzymes and methionine analogues
    Review

    Weiss, N.; Seneviranthe, C.; Jiang, M.; Wang, K.; Luo, M.
    Current Protocols (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
    Journal Article

    Alsina, M.; Landgren, O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J. G.; Kovacsovics, T.; Vesole, D. H.; Fang, B.; Kimball, A. S.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
    Journal Article

    Biran, N.; Siegel, D.; Berdeja, J. G.; Raje, N.; Cornell, R. F.; Alsina, M.; Kovacsovics, T.; Fang, B.; Kimball, A. S.; Landgren, O.
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • CARs of the future
    Review

    Daniyan, A. F.; Brentjens, R. J.
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Myeloma minimal residual disease testing in the United States: Evidence of improved standardization
    Journal Article

    Salem, D.; Stetler-Stevenson, M.; Yuan, C.; Landgren, O.
    American Journal of Hematology (2016)

    Fulltext@MSK | Save